(Q44784081)

6 December 2017

title

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging (English)

1 reference

6 December 2017

1 reference

10

1 reference

6 December 2017

11

1 reference

6 December 2017

Laura Martincich

1

1 reference

6 December 2017

Filippo Montemurro

2

1 reference

6 December 2017

Giovanni De Rosa

3

1 reference

6 December 2017

Vincenzo Marra

4

1 reference

6 December 2017

Riccardo Ponzone

5

1 reference

6 December 2017

Stefano Cirillo

6

1 reference

6 December 2017

Marco Gatti

7

1 reference

6 December 2017

Nicoletta Biglia

8

1 reference

6 December 2017

Ivana Sarotto

9

1 reference

6 December 2017

Massimo Aglietta

12

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Breast Cancer Research and Treatment

6 December 2017

published in

1 reference

6 December 2017

volume

83

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

67-76

1 reference

https://scigraph.springernature.com/pub.10.1023/b:brea.0000010700.11092.f4

6 December 2017

exact match

0 references

cites work

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Problems in evaluating response of primary breast cancer to systemic therapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Current applications and future direction of MR mammography

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Evaluation of angiogenesis and perfusion of bone marrow lesions: role of semiquantitative and quantitative dynamic MRI

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Measuring response in solid tumors: unidimensional versus bidimensional measurement

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Methodological approaches to quantitative evaluation of microcirculation in tissues with dynamic magnetic resonance tomography

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

Pathophysiologic basis of contrast enhancement in breast tumors

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010700.11092.F4

7 January 2021

10.1023/B:BREA.0000010700.11092.F4

Identifiers

DOI

1 reference

Dimensions Publication ID

6 December 2017

1045691603

0 references

1 reference